A seminar on Better access to therapies and care in Central and Eastern European countries, organised by EMSP in November 2010, in...
A presentation of patients’ use of social media.
The European Medicines Agency’s (EMA) Isabelle Moulon explains the role of the organisation.
Anthony Baron from Charles River Associates identified the factors that restrict access to MS treatment in Europe.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.